Annual report pursuant to Section 13 and 15(d)

13. Related Party Transactions (Details Narrative)

v3.19.1
13. Related Party Transactions (Details Narrative)
12 Months Ended
Dec. 31, 2017
USD ($)
Pharmsynthez [Member]  
Research and consulting expenses $ 100,000